Skip to Navigation | Skip to Main Content | Skip to Site Map

MyFloridaHouse.gov | Flsenate.gov Archives | Mobile Site

Senate Tracker: Sign Up | Login

CS/CS/HB 351: Prescription Drug Pricing Transparency

GENERAL BILL by Health and Human Services Committee ; Health Innovation Subcommittee ; Santiago ; (CO-INTRODUCERS) Davis ; La Rosa ; Payne ; Plasencia

Prescription Drug Pricing Transparency; Requires pharmacists to inform customers of certain generically equivalent drug products & whether cost-sharing obligations to such customers exceed retail price of prescription; requires registration with OIR; provides registration requirements; requires registrant to report certain changes by specified date; requires office to issue registration certificate upon receipt of completed registration form; provides for expiration; requires rulemaking; requires certain terms in health insurer or health maintenance organization contracts with pharmacy benefit managers.

Effective Date: 7/1/2018
Last Action: 2/19/2018 House - Pending review of CS -under Rule 7.18(c)
Bill Text: PDF



Bill History

Date Chamber Action
10/16/2017 House • Filed
10/26/2017 House • Referred to Health Innovation Subcommittee; Appropriations Committee; Health and Human Services Committee -HJ 33
1/9/2018 House • Introduced -HJ 33
1/12/2018 House • On Committee agenda-- Health Innovation Subcommittee, 01/17/18, 12:30 pm, Mashburn Hall
1/17/2018 House • CS by Health Innovation Subcommittee; YEAS 14 NAYS 0 -HJ 432
1/25/2018 House • Pending review of CS under Rule 7.18(c)
• CS by Health Innovation Subcommittee read 1st time -HJ 427
1/26/2018 House • Now in Appropriations Committee -HJ 444
2/2/2018 House • On Committee agenda-- Appropriations Committee, 02/06/18, 3:00 pm, Webster Hall
2/6/2018 House • Favorable by Appropriations Committee; YEAS 26 NAYS 0 -HJ 535
2/7/2018 House • Now in Health and Human Services Committee -HJ 535
2/13/2018 House • On Committee agenda-- Health and Human Services Committee, 02/15/18, 8:30 am, Morris Hall
2/15/2018 House • CS/CS by- Health and Human Services Committee; YEAS 18 NAYS 0
2/19/2018 House • Pending review of CS -under Rule 7.18(c)